Skip to main content
. 2022 May 5;37(1):1320–1326. doi: 10.1080/14756366.2022.2070909

Figure 4.

Figure 4.

Potential as lead compounds. A plot of the synthetic accessibility versus leadlikeness violations for the non-toxic, specific apPOL inhibitors is shown. Each compound is labelled with a number corresponding to the data in Supplemental file 1. The markers are coloured according to their IC50 values and the number of Lipinski violations are indicated by marker shape. A description of synthetic accessibility and leadlikeness can be found in the main text.